Press "Enter" to skip to content

Global Parkinson’s Disease Treatment Market Size, Industry Trends, Historical Data, Growth Analysis Forecast to 2030

Parkinson’s disease (PD) is a persistent neurodegenerative condition that impacts motor function, manifesting as postural instability, rigidity in the muscles and body parts, tremor in the hands, and stiffness in the motions of body parts.

In addition to depression, dysphagia, emotional fluctuations, constipation, urinary tract issues, dysarthria, sleep disturbances, and skin complications are additional symptoms of the disease.

???? Click Here to access The Full market Report :

The patients’ muscle control and mobility are significantly impaired by the disease. Moreover, the disease is affected by mechanical and non-mechanical attributes. For example, the motor symptoms of the disorder are ascribed to neuronal loss in the striatal dopaminergic area, whereas the non-motor symptoms are indicative of neuronal loss in regions of the nervous system not involved in dopaminergic processes.

As of now, the NCBI reports that no disease-modifying therapies exist for the disease. Conversely, dopaminergic medications and deep brain stimulation are employed in the medical management of Parkinson disease patients. According to reports, levodopa therapy is the most frequently used for the early phases of Parkinson’s disease and can significantly reduce patients’ tremor, bradykinesia, and muscle rigidity. Levodopa is also combined with a dopa-decarboxylase inhibitor in order to mitigate adverse effects such as nausea.

Dopamine agonists, such as ropinirole and rotigotine, are also widely prescribed medications utilised in the treatment of Parkinson’s disease. Furthermore, catecho-O-Methyltransferase inhibitors (entacapone) and monoamine oxidase B inhibitors (selegiline and rasagiline) are employed to inhibit the metabolism of dopamine. It appears that these therapies possess the capacity to reinstate dopaminergic activities in the striatum, in addition to improving motor symptoms associated with Parkinson’s disease.

???? Get more info :

The Global Parkinson’s Disease Treatment Market is segmented based on product, application and region

Global Parkinson’s Disease Treatment Market: Product Segment Analysis

● Dopamine precursors

● Monoamine oxidase B inhibitors (MAO-B inhibitors)

● Catechol-O-methyl transferase (COMT) inhibitors

● Dopamine agonists (non-ergoline)

● Carbidopa/Levodopa

● Other

Global Parkinson’s Disease Treatment Market: Application Segment Analysis

● Online pharmacies

● Retail pharmacies

● Hospital pharmacies

● Drug stores

Click on This Below Link to see Similar Insights :

The global Parkinson’s Disease Treatment market profiles key players such as:

● BIAL Pharm

● Novartis AG

● Salix Pharmaceuticals

● GlaxoSmithKline Plc

● Impax Laboratories Inc

● Daiichi Sankyo

● Wockhardt Limited

● Mylan N.V

● Cipla Inc

● Teva Pharmaceutical Industries Ltd

● Par Pharmaceutical

● Orion Corporation

● Apotex Inc

Asia-Pacific will experience the highest growth rate between 2020 and 2026

The estimated duration of the industry’s expansion in the subcontinent can be attributed to a surge in research activities concerning the treatment of Parkinson disease in countries such as Japan, China, and India, as well as favourable government policies. Furthermore, the substantial demand for generic medications and the ageing population, which is particularly susceptible to Parkinson’s disease, will contribute to the expansion of the market for Parkinson’s disease in the Asia-Pacific region.

???? Get Customization Report :

About Us :

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.

Ritesh Author
Sorry! The Author has not filled his profile.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *